AbbVie is launching Humira on the TrumpRx platform with an 86% discount under a pricing agreement with the White House. The ...
Humira will be available on TrumpRx at an 86% discount, according to media reports, as part of AbbVie's deal with the White House to avoid tariffs. The news comes less than a week after the president ...
Prescriptions for an adalimumab biosimilar among new users rose from 0% to 24% after CVS Caremark added it to its formulary, ...
Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted ...
Drug companies AbbVie and Genentech will start selling medications at lower prices through the White House’s "TrumpRx" website.
3don MSNOpinion
The price Americans pay for medicine has gotten horribly out of control. Here's how to fix it.
We can start with laws that limit the power of pharmacy-benefit managers ...
AbbVie Inc. (ABBV) is positioned for growth recovery both in terms of profits and dividends. Upcoming FQ1 2026 earnings are ...
Spun off from a Dividend King in 2013, this pharmaceutical stock is a rising star among dividend growth stocks.
Just The News on MSN
Two more major pharmaceutical companies to launch products through TrumpRx
The companies Abbvie and Genentech are expected to become the 10th and 11th drug-making companies to release their products ...
Pharmaceutical companies AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results